Molecular basis of a redox switch: molecular dynamics simulations and surface plasmon resonance provide insight into reduced and oxidised angiotensinogen.
Jennifer M CrowtherLetitia H GilmourBenjamin Thomas PorebskiSarah G HeathNeil R PattinsonMaurice C OwenRayleen FredericksAshley M BuckleConan J FeeChristoph GöblRenwick C J DobsonPublished in: The Biochemical journal (2021)
Angiotensinogen fine-tunes the tightly controlled activity of the renin-angiotensin system by modulating the release of angiotensin peptides that control blood pressure. One mechanism by which this modulation is achieved is via angiotensinogen's Cys18-Cys138 disulfide bond that acts as a redox switch. Molecular dynamics simulations of each redox state of angiotensinogen reveal subtle dynamic differences between the reduced and oxidised forms, particularly at the N-terminus. Surface plasmon resonance data demonstrate that the two redox forms of angiotensinogen display different binding kinetics to an immobilised anti-angiotensinogen monoclonal antibody. Mass spectrometry mapped the epitope for the antibody to the N-terminal region of angiotensinogen. We therefore provide evidence that the different redox forms of angiotensinogen can be detected by an antibody-based detection method.
Keyphrases
- molecular dynamics simulations
- monoclonal antibody
- blood pressure
- mass spectrometry
- molecular docking
- type diabetes
- high resolution
- gene expression
- machine learning
- single cell
- metabolic syndrome
- heart rate
- adipose tissue
- electronic health record
- ms ms
- quantum dots
- hypertensive patients
- amino acid
- dna binding
- weight loss
- label free
- transcription factor